Major depression in patients with HIV/AIDS and substance abuse.
about
Antidepressants for depression in adults with HIV infectionDepression severity is associated with increased risk behaviors and decreased CD4 cell counts.Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.Depression among HIV/AIDS Sudanese patients: a cross-sectional analytic study.Unhealthy substance-use behaviors as symptom-related self-care in persons with HIV/AIDSImplementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center.Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptylinePrevalence of Depression in People Living with HIV/AIDS Undergoing ART and Factors Associated with it.Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern TaiwanDepression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum.The effect of aging, nutrition, and exercise during HIV infection.Psychometric validation of the BDI-II among HIV-positive CHARTER study participants.Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trialPrefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.Changes in depressive symptoms and correlates in HIV+ people at An Hoa Clinic in Ho Chi Minh City, VietnamThe impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.Inhibition of Efavirenz Metabolism by Sertraline and Nortriptyline and Their Effect on Efavirenz Plasma Concentrations.Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans.Health-related quality of life in HIV-infected patients: the role of substance use.Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status.Depression Among HIV-infected Patients in Korea: Assessment of Clinical Significance and Risk Factors.The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART eraPeripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation.Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals.The Prevalence of Common Mental Disorders Among South Africans Seeking HIV Testing.The importance of identifying and treating depression in HIV infected, pregnant women: a review.Improving access to mental health services via a clinic-wide mental health intervention in a Southeastern US infectious disease clinic.The influence of depression on the progression of HIV: direct and indirect effects.Spiritual care may impact mental health and medication adherence in HIV+ populations."The sun has set even though it is morning": Experiences and explanations of perinatal depression in an urban township, Cape Town.Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia.Differential relationships between social adversity and depressive symptoms by HIV status and racial/ethnic identity.Distress, depression and anxiety among persons seeking HIV testing.HIV Patients' Preference for Integrated Models of Addiction and HIV Treatment in Vietnam.Relationship between depressive symptoms, alcohol use, and antiretroviral therapy adherence among HIV-infected, clinic-attending patients in South Africa.Symptoms of depression and anxiety among a sample of South African patients living with HIV.Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada.Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy.
P2860
Q24235613-DA778825-2559-4F3C-9C7A-E1995DE016F2Q30624490-13210E8E-1074-4BCC-82C4-7469B07B3119Q33553259-B11DB04B-9B04-4B0E-9A63-087764A60B9DQ33583560-AB4D2623-1AB2-473B-9D64-06EB8832C2F6Q34263901-EF29FB6C-42BA-4EC7-8B00-E1F30C719FDEQ34549301-FC4743B3-B019-4022-BFAE-C4D38393162FQ34597852-ABBBC18F-513A-4E74-9744-69181EFEA3F6Q34618428-D02DFEFC-8531-4A10-B631-76134B9D973FQ34818254-DFCC39DE-B152-40E9-8076-518BA18FE4C8Q35177350-D7D2CC0B-4669-4A3F-86BF-1FAE09A406ACQ35202208-E2189937-C876-4835-A61E-96B75A541E5AQ35557264-EE8F4F91-42B1-4777-8286-EF5F70E57FD7Q35639872-1E6B1B2F-EBE1-4248-AB67-B9631A150410Q35911178-3A117005-4AE5-48F3-B3A3-46844BCC4DA5Q36002565-F67BB5BA-D9A4-4976-8821-63DEEECA5661Q36164951-BB6399A1-D44C-46A3-BD39-2071AE3B342DQ36256393-2C8E7D58-FA5D-4AB9-9CE8-A4FB60CE8D09Q36346957-CC47D945-A744-4CEF-9937-CA7FD6974B46Q36571936-40B5F74E-E968-4E3B-902B-39BC78AB70A2Q36719404-947F7F50-1F3A-40F2-B13A-6BEAEE978183Q37001459-C41FBB23-C219-4291-89CB-7F665710227EQ37188602-5E98004D-0249-417A-B838-4F113B04F6AAQ37192150-6FB7C19A-20C5-4FC5-9419-4F114CF3C227Q37193610-CC0716EC-2C78-48E3-90AF-6D8CFC9DF5F9Q37211271-94392AF4-7275-46CB-90F6-6FB3D63BA1A7Q37372353-EEEC910E-D35F-4F43-9E27-F11E3FC4FE6BQ37420976-FCA5E307-3E23-42BA-B35C-CE1422120644Q37634575-7A794E2B-634E-46B4-A33B-427F61B198E5Q37730647-6521C3E8-5A42-48A8-9605-4D5CF7406441Q37956964-AA6805E9-CFAA-47CF-8538-CC0D32BBB3FEQ38685212-B4CAAAEF-47C9-4CD9-A454-0D3BF0A910C3Q40354781-73BAF56F-6140-43A4-86C7-0C7EE5883232Q40355130-1981C751-66C1-4840-B560-07A29C1FD6DEQ40418836-0C7721B9-7E87-421B-BCEA-A2E48B8909DAQ40443804-07496298-D68E-48B6-BB7A-34EBFA93949DQ40560711-A1EFDFA3-4CB7-45CB-B1FD-A2DA38780B50Q40788690-27C85F82-D48A-4091-9777-8A0498FE5EF4Q44677554-F06BDE81-BC19-420A-B853-99B9664C5C8CQ44941931-555DD780-2BDA-40F7-A932-A4977AB8C638Q45195969-0D34B16F-3224-4531-B1B7-62BFE107D88F
P2860
Major depression in patients with HIV/AIDS and substance abuse.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Major depression in patients with HIV/AIDS and substance abuse.
@en
Major depression in patients with HIV/AIDS and substance abuse.
@nl
type
label
Major depression in patients with HIV/AIDS and substance abuse.
@en
Major depression in patients with HIV/AIDS and substance abuse.
@nl
prefLabel
Major depression in patients with HIV/AIDS and substance abuse.
@en
Major depression in patients with HIV/AIDS and substance abuse.
@nl
P2093
P921
P356
P1476
Major depression in patients with HIV/AIDS and substance abuse.
@en
P2093
Carlos A Cuevas
Glenn Trezza
Jori A Berger-Greenstein
Mark A Richardson
Stephen M Brady
Terence M Keane
P304
P356
10.1089/APC.2006.0153
P577
2007-12-01T00:00:00Z